Your browser doesn't support javascript.
loading
MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2--Advanced Breast Cancer.
Neven, Patrick; Johnston, Stephen R D; Toi, Masakazu; Sohn, Joohyuk; Inoue, Kenichi; Pivot, Xavier; Burdaeva, Olga; Okera, Meena; Masuda, Norikazu; Kaufman, Peter A; Koh, Han; Grischke, Eva-Maria; Conte, PierFranco; Lu, Yi; Haddad, Nadine; Hurt, Karla C; Llombart-Cussac, Antonio; Sledge, George W.
Afiliação
  • Neven P; Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
  • Johnston SRD; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Toi M; Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Sohn J; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Inoue K; Saitama Cancer Center, Saitama, Japan.
  • Pivot X; Center Paul Strauss, Inserm U110, Strasbourg, France.
  • Burdaeva O; Arkhangelsk Regional Clinical Oncology Dispensary, Arkhangelsk, Russia.
  • Okera M; Adelaide Cancer Centre, Adelaide, Australia.
  • Masuda N; National Hospital Organization, Osaka National Hospital, Osaka, Japan.
  • Kaufman PA; University of Vermont Cancer Center, Burlington, Vermont.
  • Koh H; Kaiser Permanente, Bellflower, California.
  • Grischke EM; Universitäts-Frauenklinik Tübingen, Eberhard Karls University, Tübingen, Germany.
  • Conte P; DiSCOG University of Padova and Medical Oncology 2, Istituto Oncologico Veneto, I.R.C.C.S., Padova, Italy.
  • Lu Y; Eli Lilly and Company, Indianapolis, Indiana.
  • Haddad N; Eli Lilly and Company, Indianapolis, Indiana.
  • Hurt KC; Eli Lilly and Company, Indianapolis, Indiana.
  • Llombart-Cussac A; Hospital Arnau de Vilanova, Valencia, Spain.
  • Sledge GW; Stanford University School of Medicine, Stanford, California. gsledge@stanford.edu.
Clin Cancer Res ; 27(21): 5801-5809, 2021 11 01.
Article em En | MEDLINE | ID: mdl-34376533
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzimidazóis / Neoplasias da Mama / Antineoplásicos Hormonais / Fulvestranto / Aminopiridinas Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzimidazóis / Neoplasias da Mama / Antineoplásicos Hormonais / Fulvestranto / Aminopiridinas Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Ano de publicação: 2021 Tipo de documento: Article